Incannex Healthcare (IXHL) Depreciation and Depletion (2023 - 2026)
Incannex Healthcare (IXHL) posted quarterly Depreciation and Depletion of $100000.0 for Q1 2026, up 100.15% on a QoQ basis from -$65.9 million in Q4 2025.
Incannex Healthcare (IXHL) Depreciation and Depletion (2023 - 2026) Analysis & Trends
Incannex Healthcare (IXHL) has reported Depreciation and Depletion for 4 consecutive years, with $100000.0 the latest figure, recorded in Q1 2026.
- Quarterly Depreciation and Depletion changed N/A year-over-year to $100000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $143.0 billion (up 38.83% YoY) and the FY2025 annual result came in at $143.0 billion, up 38.83% from the prior year.
- Depreciation and Depletion climbed to $100000.0 in Q1 2026 per IXHL's latest filing, from -$65.9 million in the prior quarter.
- Over the last five years, Depreciation and Depletion for IXHL reached as high as $143.0 billion in Q2 2025 and fell as low as -$66.0 million in Q4 2024.
- A 4-year average of $27.3 billion and a median of $12.0 million in 2023 frame the typical range for Depreciation and Depletion.
- The largest YoY upside for Depreciation and Depletion was 449.43% in 2024 against a maximum downside of 264036.0% in 2024.
- Year by year, Depreciation and Depletion stood at $25000.0 in 2023, then sank by 264036.0% to -$66.0 million in 2024, then advanced by 0.13% to -$65.9 million in 2025, then jumped by 100.15% to $100000.0 in 2026.
- According to Business Quant data, Depreciation and Depletion over the past three periods registered $100000.0, -$65.9 million, and $66.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 36.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 21.60 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 7.20 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 28.00 Mn |
| 10 | Incannex Healthcare | 3.63 Mn | 3.63 Mn | - | 100,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 100,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | -65.90 Mn |
| Dec 31, 2025 | -65.90 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Sep 30, 2025 | 66.00 Mn |
| Jun 30, 2025 | 143.00 Bn |
| Jun 30, 2025 | 143.00 Bn |
| Dec 31, 2024 | -65.98 Mn |
| Dec 31, 2024 | -65.98 Mn |
| Sep 30, 2024 | 66.18 Mn |
| Sep 30, 2024 | 66.18 Mn |
| Jun 30, 2024 | 103.00 Bn |
| Jun 30, 2024 | 103.00 Bn |
| Dec 31, 2023 | 25,000.00 |
| Dec 31, 2023 | 25,000.00 |
| Sep 30, 2023 | 12.05 Mn |
| Sep 30, 2023 | 12.05 Mn |